Fusion Antibodies
Biotechnology Research • 
Lisburn, N. Ireland, United Kingdom • 21-50 Employees
Company overview
| Headquarters | 1 Springbank Road, Springbank Industrial Estate, BELFAST, Northern Ireland BT17 0QL, GB |
| Phone number | +442079338780 |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Cell Line Development, Antibody Engineering, Antibody Humanization, Antibody Sequencing Services, Invitro Diagnostic Proteins, Monoclonal Antibody Services Blast & Standard, Protein Expression & Purification Services, Affinity Maturation Services, Antibody Developability By Design |
| Founded | 2001 |
| Employees | 21-50 |
| Socials |
Key Contacts at Fusion Antibodies
Adrian Kinkaid
Chief Executive Officer
Simon Asbjø Larsen
Collaborative Research Director
Nicola Hamilton
Director Of Operations
Teresa Byrne
Director Of Quality
Fusion Antibodies Email Formats
Fusion Antibodies uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@fusionantibodies.com), used 70% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@fusionantibodies.com | 70% |
{first name}.{last name} | john.doe@fusionantibodies.com | 30% |
About Fusion Antibodies
Since 2001, Fusion Antibodies has been dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry. We offer a complete range of antibody-related services in Discovery, Engineering and Supply and have guided hundreds of projects through critical preclinical stages. Fifteen of our client’s projects have advanced to clinical stages, some as far as Phase II. We deliver a superior service for the development of antibodies by beginning each project with the end in mind. Our scientists are experts in early stage discovery of biologics. We offer this personalised service because we know that investment at the early stages saves not only millions of dollars but also months, even years of time, on projects that go awry at later stages of development. Through our vast experience we have developed a number of our own proprietary platforms for Antibody Humanization (CRX™), Affinity Maturation (RAMP™) and Developability optimisation (ADD™). Fusion Antibodies is a publicly held company, trading on the London Stock Exchange (LSE FAB.L) with headquarters in Belfast, Northern Ireland.
Fusion Antibodies revenue & valuation
| Annual revenue | $1,432,421 |
| Revenue per employee | $50,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Fusion Antibodies has 10 employees across 6 departments.
Departments
Number of employees
Funding Data
Fusion Antibodies has never raised funding before.
Fusion Antibodies Tech Stack
Discover the technologies and tools that power Fusion Antibodies's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
Analytics
JavaScript libraries
Font scripts
JavaScript libraries
Programming languages
Security
Advertising
Blogs
United States
Canada
Frequently asked questions
4.8
40,000 users
